These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32866414)

  • 21. Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database Study.
    Wang C; Gao Y; Zhu L; Huang M; Wu Y; Xuan J
    Clin Ther; 2019 Aug; 41(8):1440-1452. PubMed ID: 31155146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the relative effectiveness and tolerability of treatments of type 2 diabetes mellitus: a network meta-analysis.
    Zintzaras E; Miligkos M; Ziakas P; Balk EM; Mademtzoglou D; Doxani C; Mprotsis T; Gowri R; Xanthopoulou P; Mpoulimari I; Kokkali C; Dimoulou G; Rodopolou P; Stefanidis I; Kent DM; Hadjigeorgiou GM
    Clin Ther; 2014 Oct; 36(10):1443-53.e9. PubMed ID: 25109773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of FLAT-SUGAR: Randomized Trial of Prandial Insulin Versus Prandial GLP-1 Receptor Agonist Together With Basal Insulin and Metformin for High-Risk Type 2 Diabetes.
    ; Probstfield JL; Hirsch I; O'Brien K; Davis B; Bergenstal R; Kingry C; Khakpour D; Pressel S; Branch KR; Riddle M
    Diabetes Care; 2015 Aug; 38(8):1558-66. PubMed ID: 26068865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin added to insulin therapy in poorly controlled type 2 diabetes.
    Hirsch IB
    Diabetes Care; 1999 May; 22(5):854. PubMed ID: 10332695
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacologic treatment of type 2 diabetes: injectable medications.
    Tran L; Zielinski A; Roach AH; Jende JA; Householder AM; Cole EE; Atway SA; Amornyard M; Accursi ML; Shieh SW; Thompson EE
    Ann Pharmacother; 2015 Jun; 49(6):700-14. PubMed ID: 25802244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus.
    Meneghini LF; Traylor L; Schwartz SL
    Endocr Pract; 2010; 16(4):588-99. PubMed ID: 20350924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus.
    Bermúdez-Pirela VJ; Cano C; Medina MT; Souki A; Lemus MA; Leal EM; Seyfi HA; Cano R; Ciscek A; Bermúdez-Arias F; Contreras F; Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):194-202. PubMed ID: 17414590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Certain beginning of insulin therapy: yes, we can, but...].
    Rohrer A
    Praxis (Bern 1994); 2009 Mar; 98(6):301. PubMed ID: 19338117
    [No Abstract]   [Full Text] [Related]  

  • 29. Medicines for Treatment Intensification in Type 2 Diabetes and Type of Insulin in Type 1 and Type 2 Diabetes in Low-Resource Settings: Synopsis of the World Health Organization Guidelines on Second- and Third-Line Medicines and Type of Insulin for the Control of Blood Glucose Levels in Nonpregnant Adults With Diabetes Mellitus.
    Roglic G; Norris SL
    Ann Intern Med; 2018 Sep; 169(6):394-397. PubMed ID: 30178023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
    Dahl D; Onishi Y; Norwood P; Huh R; Bray R; Patel H; Rodríguez Á
    JAMA; 2022 Feb; 327(6):534-545. PubMed ID: 35133415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommendations for the pharmacologic treatment of hyperglycemia in type 2 diabetes. Consensus document.
    Menéndez Torre E; Lafita Tejedor J; Artola Menéndez S; Milán Núñez-Cortés J; Alonso García A; Puig Domingo M; García Solans JR; Alvarez Guisasola F; García Alegría J; Mediavilla Bravo J; Miranda Fernández-Santos C; Romero González R; ; ; ; ; ; ; ; ; ;
    Nefrologia; 2011; 31(1):17-26. PubMed ID: 21270909
    [No Abstract]   [Full Text] [Related]  

  • 32. Factors Associated with Type 2 Diabetes Mellitus Treatment Choice Across Four European Countries.
    Heintjes EM; Overbeek JA; Hall GC; Prieto-Alhambra D; Lapi F; Hammar N; Bezemer ID
    Clin Ther; 2017 Nov; 39(11):2296-2310.e14. PubMed ID: 29108837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reaching HbA1c goals with saxagliptin in combination with other oral antidiabetic drugs.
    LaSalle JR
    Postgrad Med; 2010 Jan; 122(1):144-52. PubMed ID: 20107298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of metformin and insulin versus insulin alone for type 2 diabetes: systematic review of randomised clinical trials with meta-analyses and trial sequential analyses.
    Hemmingsen B; Christensen LL; Wetterslev J; Vaag A; Gluud C; Lund SS; Almdal T
    BMJ; 2012 Apr; 344():e1771. PubMed ID: 22517929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Review: Safety and Efficacy Comparison between Sulfonylureas and Dipeptidyl Peptidase-4 Inhibitors as Second-Line Therapies in Type 2 Diabetes Mellitus.
    Gillani SW; Moosvi AF
    Curr Pharm Des; 2020; 26(34):4315-4322. PubMed ID: 32268860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GLP1-RA Add-on Therapy in Patients with Type 2 Diabetes Currently on a Bolus Containing Insulin Regimen.
    Davies ML; Pham DQ; Drab SR
    Pharmacotherapy; 2016 Aug; 36(8):893-905. PubMed ID: 27340935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.
    Thrasher J
    Am J Med; 2017 Jun; 130(6S):S4-S17. PubMed ID: 28526182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utilizing current diagnostic criteria and treatment algorithms for managing type 2 diabetes mellitus.
    Kruger DF; Boucher JL; Banerji MA
    Postgrad Med; 2011 Jul; 123(4):54-62. PubMed ID: 21680989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes.
    Mocarski M; Yeaw J; Divino V; DeKoven M; Guerrero G; Langer J; Thorsted BL
    J Manag Care Spec Pharm; 2018 Apr; 24(4):390-400. PubMed ID: 29406841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.
    Karagiannis T; Paschos P; Paletas K; Matthews DR; Tsapas A
    BMJ; 2012 Mar; 344():e1369. PubMed ID: 22411919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.